Literature DB >> 25755404

Perioperative bacterial infections in deceased donor and living donor liver transplant recipients.

Joy Varghese1, Narasimhan Gomathy2, Perumalla Rajashekhar2, Kota Venugopal2, Arikichenin Olithselvan1, Shanmugam Vivekanandan2, Shanmugam Naresh1, Chandrasekaran Sujatha3, Srinivasan Vijaya1, Venkataraman Jayanthi1, Mohamed Rela4.   

Abstract

BACKGROUND: Deceased donor (DDLT) and living donor (LDLT) liver transplant (LT) is in vogue in several centers in India. Most centers are resorting to LDLT as a preferred surgery due to shortage of deceased donor liver. The risk of infection and its effect on survival in both groups of recipients from the Indian subcontinent are not known. The study was conducted to compare the bacterial infection rates among LDLT and DDLT recipients and their impact on survival at a tertiary referral center.
METHODS: Retrospective data on 67 LT recipients were reviewed. Data on pre-, per-, and postoperative bacterial infection rates and the common isolates were obtained.
RESULTS: Thirty-five patients had LDLT and 32 had DDLT. The prevalence of pre-operative bacterial infection and the isolates was similar in both groups. The perioperative bacterial infection rates were significantly higher in DDLT recipients (P < 0.01) (relative risk: 1.44 95% confidence interval 1.04-1.9). In both LDLT and DDLT, the common source was urinary tract followed by bloodstream infection. The common bacterial isolates in either transplant were Klebsiella followed by Escherichia coli, Pseudomonas spp. and nonfermenting gram-negative bacteria. Six patients (four LDLT; two DDLT) were treated for tuberculosis. Among the risk factors, cold ischemic time, and duration of stay in the intensive care unit was significantly higher for DDLT (p < 0.01). The death rates were not significantly different in the two groups. However, the odds for death were significantly high at 26.8 (p < 0.05) for postoperative bacterial infection and 1.8 (p < 0.001) for past alcohol.
CONCLUSION: Liver transplant recipients are at high-risk for bacterial infection irrespective of type of transplant, more so in DDLT.

Entities:  

Keywords:  AFB, acid fast bacilli; ATT, anti-tuberculous treatment; BAL, bronchoalveolar lavage; BSI, bloodstream infections; Bacteria; CIT, cold ischemic time; CLSI, Clinical and Laboratory Standards Institute; CRP, C-reactive protein; DDLT, deceased donor liver transplant; E. coli, Escherichia coli; ET, endotracheal; ICU, intensive care unit; K. pneumonia, Klebsiella pneumonia; LDLT, living donor liver transplant; LT, liver transplant; MELD, model for end-stage liver disease; MRSA, methicillin-resistant Staphylococcus aureus; NFGNB, nonfermenting gram-negative bacilli; P. aeruginosa, Pseudomonas aeruginosa; RFA, radiofrequency ablation; RR, relative risk; TACE, transarterial chemoembolization; TB, tuberculosis; infection; liver transplant

Year:  2012        PMID: 25755404      PMCID: PMC3940144          DOI: 10.1016/S0973-6883(12)60081-4

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  25 in total

1.  Infectious complications in liver transplantation.

Authors:  J O Colonna; D J Winston; J E Brill; L I Goldstein; M P Hoff; J R Hiatt; W Quinones-Baldrich; K P Ramming; R W Busuttil
Journal:  Arch Surg       Date:  1988-03

2.  Mycobacterium tuberculosis in solid organ transplant recipients.

Authors:  A Subramanian; S Dorman
Journal:  Am J Transplant       Date:  2009-12       Impact factor: 8.086

Review 3.  Infections in liver transplant recipients.

Authors:  D J Winston; C Emmanouilides; R W Busuttil
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

4.  Infections after liver transplantation. An analysis of 101 consecutive cases.

Authors:  S Kusne; J S Dummer; N Singh; S Iwatsuki; L Makowka; C Esquivel; A G Tzakis; T E Starzl; M Ho
Journal:  Medicine (Baltimore)       Date:  1988-03       Impact factor: 1.889

Review 5.  Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data.

Authors:  Jon-Erik C Holty; Michael K Gould; Laura Meinke; Emmet B Keeffe; Stephen J Ruoss
Journal:  Liver Transpl       Date:  2009-08       Impact factor: 5.799

6.  Infectious complications in living-donor liver transplant recipients: a 9-year single-center experience.

Authors:  Y J Kim; S I Kim; S H Wie; Y R Kim; J A Hur; J Y Choi; S K Yoon; I S Moon; D G Kim; M D Lee; M W Kang
Journal:  Transpl Infect Dis       Date:  2008-05-26       Impact factor: 2.228

7.  Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.

Authors:  Nina Singh; Marilyn M Wagener; Timothy Gayowski
Journal:  Transplantation       Date:  2002-09-27       Impact factor: 4.939

8.  Posttransplant infections in the tropical countries.

Authors:  Vivekanand Jha; Kirpal S Chugh
Journal:  Artif Organs       Date:  2002-09       Impact factor: 3.094

9.  Infections among allogeneic bone marrow transplant recipients in India.

Authors:  B George; V Mathews; A Srivastava; M Chandy
Journal:  Bone Marrow Transplant       Date:  2004-02       Impact factor: 5.483

10.  Acquisition of methicillin-resistant Staphylococcus aureus after living donor liver transplantation: a retrospective cohort study.

Authors:  Masao Hashimoto; Yasuhiko Sugawara; Sumihito Tamura; Junichi Kaneko; Yuichi Matsui; Junichi Togashi; Kyoji Moriya; Kazuhiko Koike; Masatoshi Makuuchi
Journal:  BMC Infect Dis       Date:  2008-11-11       Impact factor: 3.090

View more
  8 in total

Review 1.  Liver Transplantation in India: At the Crossroads.

Authors:  Sanjay Nagral; Aditya Nanavati; Aabha Nagral
Journal:  J Clin Exp Hepatol       Date:  2015-11-12

2.  Gram-negative bacteria causing infective endocarditis: Rare cardiac complication after liver transplantation.

Authors:  Susan George; Joy Varghese; Sujatha Chandrasekhar; Rajasekar Perumalla; Mettu Srinivas Reddy; Venkataraman Jayanthi; Mohamed Rela
Journal:  World J Hepatol       Date:  2013-05-27

Review 3.  Bacterial infection after liver transplantation.

Authors:  Sang Il Kim
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

4.  Meta-analysis and meta-regression of outcomes for adult living donor liver transplantation versus deceased donor liver transplantation.

Authors:  Arianna Barbetta; Mayada Aljehani; Michelle Kim; Christine Tien; Aaron Ahearn; Hannah Schilperoort; Linda Sher; Juliet Emamaullee
Journal:  Am J Transplant       Date:  2021-01-05       Impact factor: 9.369

5.  Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation.

Authors:  Kuo-Hua Lin; Jien-Wei Liu; Chao-Long Chen; Shih-Hor Wang; Chih-Che Lin; Yueh-Wei Liu; Chee-Chien Yong; Ting-Lung Lin; Wei-Feng Li; Tsung-Hui Hu; Chih-Chi Wang
Journal:  PLoS One       Date:  2013-09-02       Impact factor: 3.240

6.  Predictors of postoperative infectious complications in liver transplant recipients: experience of 185 consecutive cases.

Authors:  Seungjin Lim; Eun Jung Kim; Tae Beom Lee; Byung Hyun Choi; Young Mok Park; Kwangho Yang; Je Ho Ryu; Chong Woo Chu; Su Jin Lee
Journal:  Korean J Intern Med       Date:  2018-02-23       Impact factor: 2.884

7.  High mortality associated with gram-negative bacterial bloodstream infection in liver transplant recipients undergoing immunosuppression reduction.

Authors:  Fang Chen; Xiao-Yun Pang; Chuan Shen; Long-Zhi Han; Yu-Xiao Deng; Xiao-Song Chen; Jian-Jun Zhang; Qiang Xia; Yong-Bing Qian
Journal:  World J Gastroenterol       Date:  2020-12-07       Impact factor: 5.742

8.  Concurrent Change in Serum Cholinesterase Activity and Midregional-Proadrennomedullin Level Could Predict Patient Outcome following Liver Transplantation.

Authors:  Sebastian O Decker; Albert Krüger; Henryk Wilk; Florian Uhle; Thomas Bruckner; Stefan Hofer; Markus A Weigand; Thorsten Brenner; Aleksandar R Zivkovic
Journal:  Biomolecules       Date:  2022-07-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.